Page last updated: 2024-12-11

4-(carboethoxyphenyl)retinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

viaminate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6438483
SCHEMBL ID7159291
MeSH IDM0111094

Synonyms (28)

Synonym
AC-15391
53839-71-7
4-(ethoxycarbophenyl)retinamide
brn 2916567
4-(carboethoxyphenyl)retinamide
retinamide, n-(4-(ethoxycarbonyl)phenyl)-
n-(4-(ethoxycarbonyl)phenyl)retinamide
retinamide ethyl benzoate
n-(4-ethoxycarbophenyl)retinamide
ethyl 4-[[(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]amino]benzoate
viaminate
SCHEMBL7159291
unii-ue38ree8gq
ue38ree8gq ,
AKOS015894826
ethyl 4-(3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamido)benzoate
ethyl 4-((2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamido)benzoate
2519551-17-6
mfcd01684778
AS-13271
retinamide, n-[4-(ethoxycarbonyl)phenyl]-
ethyl4-(3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamido)benzoate
DTXSID301318689
4-(carboethoxyphenyl)retinamide [who-dd]
2699657-53-7
ethyl 4-(((2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoyl)amino)benzoate
ethyl 4-((2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamido)benzoate
n-[4-(ethoxycarbonyl)phenyl]retinamide; n-(p-ethoxycarbonylphenyl)retinamide; n-[4-(ethoxycarbonyl)phenyl]-retinamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's1 (7.69)18.2507
2000's2 (15.38)29.6817
2010's2 (15.38)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (21.43%)4.05%
Observational0 (0.00%)0.25%
Other10 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]